StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 29 Mar 2022 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Press+Releases/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html for the full story. http://www.streetinsider.com/Business+Wire/FDA+Grants+Orphan+Drug+Designation+to+Noxopharm+for+Sarcoma+Treatment/19835658.html Tue, 29 Mar 2022 08:00:00 -0400 A.06822034 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Press+Releases/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html for the full story. http://www.streetinsider.com/Business+Wire/Sarcoma+Trial+for+New+Cancer+Treatment+Begins+at+City+of+Hope+in+Los+Angeles/19741299.html Tue, 08 Mar 2022 08:00:00 -0400 A.33615634 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+In-Licenses+Novel+RNA+Technology+From+Hudson+Institute+of+Medical+Research/19293215.html Wed, 01 Dec 2021 08:00:00 -0400 A.37317906 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Announces DARRT-2 Clinical Trial in U.S. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html for the full story. http://www.streetinsider.com/Business+Wire/Noxopharm+Announces+DARRT-2+Clinical+Trial+in+U.S./19181822.html Tue, 09 Nov 2021 08:00:00 -0400 A.33615634 NOX NYR Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19 http://www.streetinsider.com/Press+Releases/Noxopharm+Preclinical+Data+Further+Supports+Anti-Inflammatory+Role+of+Idronoxil+in+the+Treatment+of+COVID-19/18866543.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Noxopharm+Preclinical+Data+Further+Supports+Anti-Inflammatory+Role+of+Idronoxil+in+the+Treatment+of+COVID-19/18866543.html for the full story. http://www.streetinsider.com/Press+Releases/Noxopharm+Preclinical+Data+Further+Supports+Anti-Inflammatory+Role+of+Idronoxil+in+the+Treatment+of+COVID-19/18866543.html Thu, 26 Aug 2021 08:00:00 -0400 A.37317906 NOX NYR